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Summary 
The 75 kDa tumor necrosis factor receptor (TNFRP) 
transduces extracellular signals via receptor-associated 
cytoplasmic proteins. Two of these signal transduc- 
ers, TRAFl and TRAFP, were isolated and character- 
ized previously. We report here the biochemical purifi- 
cation and subsequent molecular cloning of two novel 
TNFRZ-associated proteins, designated c-IAPl and 
c-IAP2, that are closely related mammalian members 
of the inhibitor of apoptosis protein (IAP) family orgi- 
nally identified in baculoviruses. The viral and cellular 
IAPs contain N-terminal baculovirus IAP repeat (BIR) 
motifs and a C-terminal RING finger. The c-IAPs do 
not directly contact TNFRS, but rather associate with 
TRAFl and TRAF2 through their N-terminal BIR 
motif-comprising domain. The recruitment of c-IAPl 
or c-IAP2 to the TNFRS signaling complex requires a 
TRAF2-TRAFl heterocomplex. 
Introduction 
Tumor necrosis factor (TNF) is a cytokine that mediates 
pleiotropic inflammatory and immunoregulatory responses 
via two distinct cell surface receptors of approximately 55 
kDa (TNFRl) and 75 kDa (TNFR2) (reviewed by Tartaglia 
and Goeddel, 1992; Rothe et al., 1992; Vandenabeele et 
al., 1995). Both TNFRs are members of the larger TNFR 
superfamily, which includes the Fas antigen, the lympho- 
toxin-8 receptor, CD40, and CD30, among others (re- 
viewed by Smith et al., 1994). Signaling within this receptor 
family is triggered by receptor clustering upon binding of 
the respective trimeric ligands to the conserved extracellu- 
lar domains (reviewed by Tartaglia and Goeddel, 1992; 
Smith et al., 1994; Vandenabeele et al., 1995). 
Similar to the related Fas antigen, TNFRl has been 
widely characterized to mediate TNF-induced apoptosis, 
also known as programmed cell death (reviewed by Smith 
et al., 1994). This naturally occurring process of cell sui- 
cide plays a crucial role in the development and mainte- 
nance of multicellular organisms by eliminating superflu- 
ous or unwanted cells (reviewed by Raff, 1992). Although 
TNFRP is capable of transducing apoptotic signals in cer- 
tain cell lines (Grell et al., 1993), ligation of TNFR2 by TNF 
does usually not trigger cell death. Rather, TNFR2 has 
been implicated in cell proliferation or survival, e.g., in 
thymocytes, where TNF-induced proliferation is specifi- 
cally mediated by TNFR2 (Tartaglia et al., 1991, 1993a). 
The cytoplasmic domains of members of the TNFR fam- 
ily do not possess sequences indicative of catalytic activ- 
ity, nor do they show resemblance to components of other 
known signal transduction pathways (reviewed by Tartag- 
lia and Goeddel, 1992; Smith et al., 1994). Elucidation of 
the intracellular events involved in signaling by TNF and 
related cytokines has begun to emerge from studies lead- 
ing to the identification of several proteins that associate 
with the cytoplasmic domains of the cognate receptors 
(Rothe et al., 1994; Hu et al., 1994; Cheng et al., 1995; 
Mosialos et al., 1995; Sato et al., 1995a, 1995b; Song 
and Donner, 1995; Hsu et al., 1995; Boldin et al., 1995; 
Chinnaiyan et al., 1995; Stanger et al., 1995). TNFR- 
associated factor 1 (TRAFl) and 2 (TRAF2) were found 
to interact with a region within the cytoplasmic domain of 
TNFR2that is requiredforsignaltransduction(Rotheetal., 
1994). In the yeast two-hybrid system, TNFR2 associates 
directly with TRAF2, whereas its interaction with TRAFl is 
dependent upon TRAF2 heterocomplex formation. TRAF2 
and a third TRAF family member, TRAFS, also bind to 
the cytoplasmic domain of CD40 and, presumably, other 
members of the TNFR superfamily(Hu et al., 1994; Cheng 
et al., 1995; Mosialoset al., 1995; Sato et al., 1995a; Rothe 
et al., 1995). TRAFl and TRAF2 share a conserved 
C-terminal TRAF domain of approximately 230 amino 
acids that is involved in oligomerization and receptor asso- 
ciation (Rothe et al., 1994). Inspection of this region in 
TRAF3 identified two subdomains, the TRAF-C domain, 
comprising the C-terminal 150 amino acids, and the 
TRAF-N domain, which consists of a putative coiled coil 
(Cheng et al., 1995). Whereas the TRAF-C domain is 
highly conserved among the three known TRAFs, the 
TRAF-N domain is diverged in TRAFS. In additon, TRAF2 
and TRAFB contain an N-terminal RING finger and five 
zinc finger structures of weak sequence similarity (Rothe 
et al., 1994; Hu et al., 1994; Cheng et al., 1995; Mosialos 
et al., 1995; Sato et al., 1995a; Song and Donner, 1995). 
Both TNFR2 and CD40 can signal activation of the tran- 
scription factor NF-KB (Rothe et al., 1994; LEgreid et al., 
1994; Berberich et al., 1994; Sarma et al., 1995). Func- 
tional analysis demonstrated that TRAF2 is a common 
signal transducer for TNFR2 and CD40 that mediates acti- 
vationof NF-KB bythesetwo receptors(Rotheetal., 1995). 
This effector function of TRAF2 requires its N-terminal 
RING finger domain. The role of TRAFB in signal transduc- 
tion is less well defined, but it has been implicated in CD40- 
mediated induction of CD23 (Cheng et al., 1995). 
Here we report the isolation and characterization of two 
novel components of the TNFR2 signaling complex, desig- 
nated c-IAP1 and c-IAP2. Sequence analysis suggests 
that c-IAPl and c-IAP2 are cellular members of the bacu- 
loviral inhibitor of apoptosis protein (IAP) family. Biochemi- 
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Figure 1. Purification of TNFRP-Associated Proteins 
Large-scale purification of TNFRP-associated proteins from CT6 cells 
by GST-hTNF-RPicd fusion protein affinity chromatography was per- 
formed as described in Experimental Procedures. An aliquot of the 
purified material was analyzed by SDS-PAGE and silver staining. The 
protein bands of 68 kDa and 66 kDa that were eluted specifically from 
the wild-type GST-hTNF-R2icd fusion protein affinity column com- 
pared with the control GST-hTNF-R2icd(-37) fusion protein column 
are marked. Arrows indicate the 45 kDa TRAFl band and the 56 kDa 
TRAFP band. Positions of molecular mass standards (in kilodaltons) 
are shown on the left. 
cal studies indicate that both c-IAPs are recruited to 
TNFR2 via their interaction with a TRAF2-TRAW hetero- 
complex. 
Results 
Purification and Molecular Cloning of the 66 kDa 
TNFRP-Associated Protein 
Previous biochemical analysis had identified three cyto- 
plasmic proteins of approximately 45 kDa, 56 kDa, and 
68 kDa that associate with a 78 amino acid C-terminal 
region of human TNFR2 (hTNFR2) involved in signaling 
(Rothe et al., 1994). Subsequent large-scale purification, 
followed by partial amino acid sequencing and molecular 
cloning, led to the isolation of the cDNAs for TRAFl and 
TRAF2, corresponding to the 45 kDa and 58 kDa proteins, 
respectively (Rothe et al., 1994). In contrast, the amount 
of 68 kDa TNFR2-associated protein initially purified was 
insufficient for generating partial amino acid sequence. 
The 68 kDa TNFRP-associated protein was purified on 
a larger scale from 120 liters of murine CT6 cells by affinity 
chromatography using a fusion protein between glutathi- 
one S-transferase (GST) and the intracellular domain of 
hTNFR2 (GST-hTNF-RPicd) as described in Experimen- 
tal Procedures. The purification yielded two protein bands 
of approximately 88 kDa and 66 kDa (Figure 1; see also 
Figure 2. Homology between c-IAP1 and c-IAP2 
An optimized alignment of the protein se- 
quences of murine and human c-IAPI and hu- 
man c-IAP2 is shown. Identical amino acids 
are boxed. Brackets indicate the boundaries of 
the three BIR motifs. The arrow delineates 
the boundary of the C-terminal RING finger 
domain. 
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Figure 3. Sequence Similarity of c-IAPl and 
c-IAP2 with other Proteins 
(A) Diagrams of the putative domain structure 
of IAP family members. Shown are the posr- 
tions of the conserved BIR motifs and RING 
finger domains of human c-IAPl, OplAP, and 
NAIP. 
(B) Optrmized alignment of BIR motifs of IAP 
family members. The sequences are com- 
pared both among and withrn different mem- 
bers of the IAP family. Residues corresponding 
to the consensus sequence are stippled. Aster- 
isks in the consensus sequence represent hy 
drophobic residues. See text for details. 
(C)Comparison of amino acid sequences con- 
taining RING finger motifs. The RING finger 
domains of clAPi and c-IAP2 are aligned with 
the respective zinc-binding motifs of v-IAPs 
and TRAFs (see text), the products of the neu- 
ralizedgene from D. melanogaster and the hu- 
man proto-oncogene c-cbl, the human 52 kDa 
ribonculeoprotein SS-A/Ro. and human RING1 
and MDMZ(see Freemont, 1993; Schwabeand 
Ktug, 1994). Residues corresponding to the 
consensus sequence are stippled. 
Figure 2D in Rothe et al., 1994). Both proteins were individ- 
ually digested with proteases, and the amino acid se- 
quence of internal peptideswasdetermined. Peptides with 
common sequences were found in the two proteins, sug- 
gesting that the 66 kDa protein may represent a degrada- 
tion product or modification of the 68 kDa protein (data 
not shown). Fully degenerate oligonucleotides corre- 
sponding to two isolated peptides from the 68 kDa protein, 
YYIGPGD and EEMASGD, were used to amplify a 0.75 
kb DNA fragment from mouse CT6 RNA by reverse tran- 
scription-polymerase chain reaction (RT-PCR). This DNA 
fragment was used to isolate a 2.85 kb cDNA clone from 
a mouse CT6 cDNA library. DNA sequence analysis of 
this cDNA clone revealed an open reading frame encoding 
a 612 amino acid protein with a predicted molecular mass 
of 69 kDa (Figure 2). Three additional peptides obtained 
from protein sequencing, QIPLQAR, KEIDSTLYENLF- 
VEK, and TVRTFLS, were found in the translated mouse 
protein. These results confirm that the 2.85 kb cDNA clone 
encodes the purified murine 68 kDa TNFRBassociated 
protein. 
c-IAPl Is a Novel Member of the IAP Family 
of RING Finger Proteins 
A database search did not reveal any proteins identical 
in primary amino acid sequence to the murine 68 kDa 
TNFRBassociated protein. However, substantial sequence 
similarity was observed with members of the IAP family 
previously found in baculoviruses (reviewed by Clem and 
Miller, 1994). The 68 kDa protein was therefore designated 
cellular IAPl (c-IAPl), and we henceforth refer to its viral 
counterparts as v-IAPs. 
Comparison of the primary structure of murine c-IAPl 
and v-IAPs indicates that they are composed of at least 
two distinct domains (Figures 2 and 3). The N-terminal 
region of members of the IAP family contains characteris- 
tic tandem repeat units spanning approximately 70 amino 
acids that have been termed baculovirus IAP repeat (BIR) 
motifs (Birnbaum et al., 1994; Figures 3A and 3B). Among 
v-IAPs, the BIR motifs of the IAP from Orgyia pseudotsu- 
gata nuclear polyhedrosis virus (OplAP; Birnbaum et al., 
1994) are 68% and 30% identical with the equivalent do- 
mains of the IAPs from Cydia pomonella granulosis virus 
Cell 
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(CplAP; Crook et al., 1993) and from Autographa califor- 
nica nuclear polyhedrosis virus (AclAP; Braunagel et al., 
1992), respectively (Figure 38). The repeat motifs within 
the BIR domain of murine c-IAPl (amino acids l-329) 
share 50% amino acid identity with OplAP, 42% identity 
with CplAP, and 30% identity with AclAP (Figure 3B). In 
addition, c-IAPl displays 43% amino acid identity in its 
BIR motifs with the recently identified neuronal apoptosis 
inhibitory protein (NAIP) (Figure 38) a mammalian IAP- 
related protein that has been implicated in spinal muscular 
atrophy disorders in humans (Roy et al., 1995). The BIR 
motifs of NAIP show 33% identity with v-IAPs (Roy et al., 
1995; Figure 38). This comparative analysis demonstrates 
that the BIR domains of mammalian c-IAPl and NAIP are 
roughly as closely related to the corresponding domains 
of v-IAPs as those are to one another, suggesting an evolu- 
tionary conserved function for this structural motif. How- 
ever, whereas the BIR domains of known v-IAPs are com- 
prised of two repeat motifs, mammalian c-IAPl and NAIP 
possess three tandem repeats (Figures 3A and 38). The 
three BIR motifs of c-IAPl are 33% identical (Figure 38). 
The C-terminal domain of v-IAPs contains a RING finger 
motif (reviewed by Clem and Miller, 1994; Figures 3A and 
3C). This zinc-binding domain is also present in c-IAPl 
but missing in NAIP (Figures 3A and 3C). The RING finger 
domain of c-IAPl (amino acids 561-612) shares 42% and 
36% identity over 52 amino acids with OplAP (or CplAP) 
and AclAP, respectively (Figure 3C). In comparison, the 
RING finger domains of OplAP and CplAP are 54% identi- 
cal, whereas they exhibit only 25% identity with the RING 
finger domain of AclAP. RING finger structures have also 
been observed at the N-terminus of TRAF2 and TRAF3, 
where they mediate effector functions (Rothe et al., 1994, 
1995; Cheng et al., 1995). Whereas the IAP RING finger 
motifs display a distribution of hydrophobic and charged 
residues that resembles several other RING finger family 
members (see Freemont, 1993) they do not share signifi- 
cant similarity with theTRAF RING finger domains beyond 
the conserved cysteine and histidine residues (Figure 38). 
c-IAPl and c-IAP2 Are Closely Related Members 
of the IAP Family 
To obtain the human homolog of murine c-IAPl, we 
screened a human HeLa cDNA library with a murine 
c-/A/? DNA probe under reduced hybridization strin- 
gency. Two distinct human cDNA clones of approximately 
2.6 kb were isolated. One cDNA clone encoded a 70 kDa 
protein of 618 amino acids that is 84% identical to mouse 
c-IAPl, suggesting that it represents the human homolog 
of murine c-IAPl. The other human cDNA clone predicted 
a 68 kDa protein of 604 amino acids that is a second cellu- 
lar member of the IAP family, termed c-IAP2. c-IAP2 is 
closely related to both murine and human c-IAPl, sharing 
72% and 73% amino acid identity, respectively. 
Like murine c-IAPl, human c-IAPl and c-IAP2 contain 
three N-terminal BIR motifs and a C-terminal RING finger 
domain (Figures 2 and 3). In v-IAPs, these two domains 
are separated by a short linker region of approximately 
30-50 amino acids (Clem and Miller, 1994). In contrast, 
this region extends over roughly 230 amino acids in both 
murine and human c-IAPl (amino acids 330-560 and 337- 
566, respectively) as well as human c-IAP2 (amino acids 
223-552) (see Figure 2). This protein domain displays 
strong sequence conservation among c-IAPs (87% iden- 
tity between mouse and human c-IAPl and 70% identity 
between human c-IAPl and c-IAP2; see Figure 2) but 
does not bear any resemblance to v-IAPs nor to other 
known proteins. 
The discovery of two closely related human IAPs along 
with their characterization as TNFR2-associated proteins 
(see below) suggests that the purified 66 kDa protein (see 
above) is probably the murine homolog of human c-IAP2 
rather than a degradation product or modification of the 
purified 68 kDa protein. 
Tissue Distribution of c-IA/J mRNA 
Northern blot analysis indicated that murine c-IAPl is the 
translation product of a 4.1 kb mRNA expressed constitu- 
tively in mouse tissues (heart, brain, spleen, lung, liver, 
skeletal muscle, kidney, and testis; Figure 4A). Similarly, 
low levels of human c-IAP7 and c-IAP2 transcripts of ap- 
proximately 4.3 kb and 6 kb, respectively, were detected 
in all human tissues examined (spleen, thymus, prostate, 
testis, ovary, small intestine, colon, and peripheral blood 
leukocytes; Figures 48 and 4C). Human c-IAP7 mRNA 
was most abundant in thymus, testis, and ovary (Figure 
4B), whereas human c-IAP2 expression was highest in 
spleen and thymus (Figure 4C). 
The BIR Domains of c-IAPl and c-IAP2 Interact 
with the TRAF-N Domains of TRAFl and TRAFS 
Although the subsequent functional analysis of mamma- 
lian c-IAPs is described for c-IAPl only, virtually identical 
results were obtained for c-IAP2 (data not shown). Thus, 
functional distinction between these closely related mem- 
bers of the IAP family was not apparent. 
The functional properties of c-IAPl as a TNFR2- 
associated protein were investigated in mammalian cells. 
Human c-IAPl containing an N-terminal Myc epitope was 
transiently expressed in human embryonic kidney 293 
cells. Cell lysates were incubated with various GST- 
hTNF-RPicd fusion proteins (Rothe et al., 1994), and spe- 
cific binding of c-IAPl was detected using an anti-Myc 
antibody. This analysis demonstrated that c-IAPl copre- 
cipitates with GST fusion proteins containing the wild-type 
cytoplasmic domain of TNFR2 and the cytoplasmic do- 
mains of the functional receptor mutants hTNFR2(-16) 
and hTNFR2(A304-345) (Figure 5A). However, c-IAPl 
did not coprecipitate with GST fusion proteins compris- 
ing the cytoplasmic domains of the inactive mutants 
hTNFR2(-37) and hTNFR2(-59) (Figure 5A). These find- 
ings confirmed that the cloned c-IAPl corresponds to the 
endogenous 68 kDa TNFR2-associated protein and sug- 
gest that c-IAPl is involved in TNFR2 signaling. 
Next we used the yeast two-hybrid system to determine 
whether the observed coprecipitation of c-IAPl and 
TNFR2 in cell extracts is mediated by direct association or 
via other TNFRSassociated proteins. Two-hybrid analysis 
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Figure 4. Northern Blot Analysis of c-/API and c-IAP2 mRNA in Mouse 
and Human Tissues 
Mouse (A) and human (E3 and C) multiple tissue Northern blots were 
hybridized with radrolabeled murine (A) and human c-/API (B) and 
human dAP2 (C) probes. Arrows mark the postitions of specrfic tran- 
scripts of the respective c-/APs Molecular mass standards (in kilo- 
bases) are indrcated on the left rn each panel. 
failed to reveal a direct interaction of c-IAPl with the cyto- 
plasmic domain of TNFR2 (Figure 6A). However, direct 
association could be detected between c-IAPl and both 
TRAFl and TRAF2 (Figure 6A). The conserved TRAF do- 
main of TRAF2 (amino acids 264-501) was sufficient to 
mediate this interaction, and a mutant TRAF2 protein de- 
void of the entire TRAF domain (TRAF2[1-250)) did not 
associate with c-IAPl (Figure 66). Further two-hybrid anal- 
ysis demonstrated that a mutant TRAF2 protein lacking 
the TRAF-C domain (TRAF2[ l-3581) still associated with 
c-IAPl (Figure 66) but had lost its ability to bind to the 
cytoplasmic domain of TNFR2 (Figure 66). In addition, no 
interaction could be detected between c-IAPl and TRAFB 
Myc-c-IAPl IO 10 10 10 IO 10 10 
B 
Flag-c-IAPl 5 5 
HA-TRAFS 5 
HA-TRAF2 
Myc-c-IAPI 5 5 5 
Flag-TRAFI 5 5 
Flag-TRAF2 5 5 
5 
5 
C 
Myc-c-IAPl 5 55555555 
TNF-R2 5 5 5 5 5 5 5 5 5 
TRAFI 5 2.5 2.5 2.5 
TRAF2 5 2.5 2.5 2.5 
TRAF3 5 2.5 2.5 2.5 
Frgure 5 Interaction of c-IAPl wrth TNFR2 and TRAFs 
(A) Interactron of c-IAPl with the intracellular regrons of TNFR2 mu- 
tants expressed as GST fusion proteins. 293 ceils (5 x 106) were 
transiently transfected wrth the indicated amounts (in micrograms) of 
an expression vector encoding Myc eprtope-tagged clAPI, After 36 
hr, lysates were prepared and incubated with the indicated GST fusion 
proteins. Coprecipitahng Myc-tagged clAPI was detected by immu- 
noblot analysrs using the antr-Myc monoclonal antrbody. Note that the 
association of c-IAPI with TNFR2 IS indirect and can only be observed 
when the coprecrpitation is performed In larger scale cell lysates, which 
provide suffrcrent amounts of endogenous TRAFl and TRAF2 (see 
below). 
(B) Interactron of c-IAPl with TRAFs. 293 cells were transiently 
transfected with the indicated amounts (in micrograms) of epitope- 
tagged c-IAPl and TRAF expression vectors. After 24 hr, alrquots 
of cell lysates were immunoprecrpitated wrth anti-FLAG monoclonal 
antrbody. Coprecrpitating Myc-tagged c-IAPl and HA epitope-tagged 
TRAFs were detected by immunoblot analysrs using the anti-Myc 
monoclonal antrbody(right) and the anti-HA monoclonal antibody(left). 
(C) TRAF2-TRAFI-mediated Interactron of c-IAPI wrth TNFRP. 293 
cells (2 x 106) were transrently transfected with the Indicated amounts 
(In mrcrograms) of TNFRZ, TRAF, and Myc epitope-tagged c-/API ex- 
pressron vectors for 24 hr. Aliquots of cell lysates (one frth) were immu- 
nopreciprtated with polyclonal antibody to TNFR2. Coprecrprtatrng 
Myc-tagged c-IAPl was detected by immunoblot analysrs usrng the 
anti-Myc monoclonal antibody 
The positions of molecular mass markers (in krlodaltons) are shown 
on the left rn all panels. 
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Figure 6. Mapping of the c-IAP-TRAF Interac- 
tion Domain 
(A) Interaction of c-IAPl with TRAFs. Expres- 
sion vectors encoding wild-typeor deletion mu- 
tants of clAPi fused with the GAL4 DNA- 
binding domain were cotransformed into yeast 
Y190 cells with plasmids expressing GAL4 
transcription activation domain-TRAFor GAL4 
transcription activation domain-TNFRZ fusion 
proteins. Each transformation mixture was 
plated on a synthetic dextrose plate lacking 
tryptophan and leucine. At least 200 trans- 
formants were obtained per plate. Filter assays 
for 8-galactosidose activity were performed to 
detect interaction between fusion proteins. 
Plus signs represent blue color development 
of the transformants within 2 hr of the assay; 
minus signs indicate lack of color development 
assessed after 24 hr. Identical results were ob- 
tained with equivalent GAL4 DNA-binding do- 
main hybrids of c-IAP2 (data not shown). 
(B) Interaction of TRAF2 with c-IAPs. Yeast 
Y190 cells were cotransformed with expres- 
sion vectors encoding wild-type or deletion mu- 
tants of TRAFZ fused with the GAL4 DNA- 
binding domain and plasmids expressing 
GAL4 activation domain-c-IAP or GAL4 activation domain-TNFRP fusion proteins. Interactions between fusion proteins were analyzed as described 
(see above). Control transformations with empty GAL4 vectors were negative and are not listed. 
(Figure 6A). These results indicate that the TRAF-N do- 
main of TRAFP (amino acids 264-358) is required for inter- 
action with c-IAPl. In contrast, the TRAF-C domain of 
TRAFP (amino acids 359-501) is essential for association 
with TNFR2 but dispensable for interaction with c-IAPl. 
Thus, c-IAPl and TNFR2 bind to nonoverlapping sites 
within the TRAF domain of TRAF2. 
Whereas TRAFl and TRAFP can form homo- and heter- 
omeric complexes, no homo- or heterodimerization of 
c-IAPl and c-IAP2 wasobserved either by two-hybrid anal- 
ysis or coimmunoprecipitation experiments (data not 
shown). Mutational analysis of human c-IAPl was per- 
formed to investigate the structural requirements for its 
association with TRAFs. In the yeast two-hybrid system, 
the C-terminal RING finger domain of c-IAPl was expend- 
able for interaction with TRAFs, since a mutant c-IAPl 
protein lacking this domain (c-IAPl [l-570])still associated 
with TRAFl and TRAF2 (Figure 6A). Further deletion anal- 
ysis indicated that the region of c-IAPl containing the BIR 
motifs mediates the interaction with TRAFs, since a mu- 
tant c-IAPl protein comprising the N-terminal half of the 
molecule (c-IAPl[l-3961) associated with TRAFl and 
TRAF2 whereas a mutant protein devoid of BIR motifs 
(c-IAP1[322-6181) lacked this ability (Figure 6A). This ob- 
servation suggests that BIR motifs of IAPs may constitute 
a protein-protein interaction domain. 
c-IAPl and c-IAP2 Are Components of TNFRS-TRAF 
Signaling Complex 
A transfection-based coimmunoprecipitation assay was 
used to further investigate the interaction of c-IAPl with 
components of the TNFR2-TRAF complex in mammalian 
cells. An expression vector encoding the Myc epitope- 
tagged human c-IAPl was transfected alone or with ex- 
pression vectors encoding FLAG epitope-tagged murine 
TRAFl orTRAF2 into 293 cells. Cell lysates were immuno- 
precipitated using a monoclonal antibody against the 
FLAG epitope, and coprecipitating c-IAPl was detected 
by immunoblotting with an anti-Myc monoclonal antibody. 
Both TRAFl and TRAF2 coprecipitated c-IAPl (see Figure 
58). FLAG epitope-tagged murine c-IAPl was also able to 
coprecipitate hemagglutinin (HA) epitope-tagged human 
TRAF2 but not TRAFB (see Figure 5B). Thus, as had been 
observed in the yeast two-hybrid system, c-IAPl associ- 
ates with TRAFl and TRAF2 but not TRAF3 in mammalian 
cells. Similarly, the interaction of mutant c-IAPl and TRAF 
proteins in coprecipitation experiments confirmed the re- 
sults obtained by two-hybrid analysis (data not shown). 
Because the interaction between c-IAPl and TNFR2 
was found to be indirect and both proteins bind to distinct 
regions within TRAF2, we reasoned that TRAF2 was likely 
to mediate the association of c-IAPl with TNFR2. Simi- 
larly, TRAF2 has been shown to mediate the interaction 
between TNFRP and TRAFl in the yeast two-hybrid sys- 
tem (Rothe et al., 1994). To test this assumption, TNFR2 
and Myc epitope-tagged c-IAPl were coexpressed in 293 
cells in the absence or presence of overproduced TRAF 
proteins. Cell lysates were immunoprecipitated with poly- 
clonal anti-TNFR2 antibodies, followed by immunoblotting 
with anti-Myc monoclonal antibody. In this assay, TNFR2 
did not coprecipitate detectable levels of c-IAPl through 
endogenous factors since the amount of cell extract used 
for immunoprecipitation was approximately 25-fold less 
than in the coprecipitation experiments with GST-hTNF- 
R2icd fusion proteins (see above) (see Figure 5C). Surpris- 
ingly, coexpression of neither TRAFl norTRAF2 was suffi- 
cient to mediate association of TNFR2 with c-IAPl (see 
Figure 5C). However, when equivalent amounts of both 
TRAFl and TRAF2 were coexpressed with TNFR2 and 
c-IAPl, strong coprecipitation of c-IAPl with TNFRP was 
Association of c-IAPs with the TNFR2-TRAF Complex 
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detected (see Figure 5C). This association of TNFR2 and 
c-IAPl was specifically mediated by the TRAFl-TRAF2 
heterocomplex, since it was not observed upon coexpres- 
sion of either TRAFl or TRAM with TRAFB (see Figure 
5C). These findings demonstrate that whereas c-IAPl is 
capable of associating directly with TRAFl and TRAF2, 
its interaction with TNFR2 is indirect and requires both 
TRAFl and TRAF2. c-IAP2 behaved indistinguishably 
from c-IAPl in this analysis (data not shown). Thus, both 
c-IAPl and c-IAP2 constitute components of the TNFR2 
signaling complex. 
Discussion 
The recent identification of two distinct families of signal 
transducers has provided insights into how members of 
the TNFR superfamily initiate downstream signaling 
events (reviewed by Vandenabeele et al., 1995). These 
signaling proteins contain either death domains or TRAF 
domains and are involved in signal transduction by either 
TNFRl and the Fas antigen or TNFR2, CD40, and, pre- 
sumably, other TNFR family members, respectively. We 
now report the identification and molecular characteriza- 
tion of a third class of putative intracellular signal transduc- 
ers for this diverse group of cell surface receptors. c-IAPl 
and c-IAP2 were found in association with the cytoplasmic 
domain of TNFR2 and are closely related mammalian 
members of the expanding IAP family originally identified 
in baculoviruses (Clem and Miller, 1994). 
The common structural feature of all IAP family members 
are tandem repeat units, termed BIR motifs, of the general 
consensus sequence XBRX20-23GX1,CX2CX16HXsCX3 (Birn- 
baum et al., 1994; Figure 38). The spacing of cysteine and 
histidine residues within the BIR motifs raises the possibil- 
ity of metal ion coordination and nucleic acid binding, simi- 
lar to known metal ion-containing protein motifs (Birn- 
baum et al., 1994). Our mutational analysis of c-IAPl and 
c-IAP2 provides evidence that the BIR motif-containing 
domain of these two IAPs facilitates protein-protein inter- 
action, allowing these proteins to associate with TRAFs. 
This finding suggests that other viral and cellular members 
of the IAP superfamily may interact with still unidentified 
TRAF-related proteins as part of their mechanism of action. 
In addition to BIR motifs, all known IAP family members 
contain RING finger domains, with the exception of NAIP. 
This sequence motif has been observed in a wide variety 
of nuclear and cytoplasmic proteins and is thought to form 
two zinc-binding finger structures involved in protein-DNA 
interactions and possibly protein-protein interactions (re- 
viewed by Schwabe and Klug, 1994). Unlike most RING 
finger proteins characterized to date, the IAP RING finger 
domains are located C-terminally rather than N-terminally 
(Birnbaum et al., 1994). N-terminal RING finger domains 
are also present in two members of the TRAF family, 
TRAFP and TRAF3 (Rothe et al., 1994; Hu et al., 1994; 
Cheng et al., 1995; Mosialos et al., 1995; Sato et al., 
1995a; Song and Donner, 1995). The TRAF2 RING finger 
domain is required for TRAFP-mediated NF-KB activation 
(Rothe et al., 1995). By analogy, the RING finger domains 
of IAPs may represent effector or regulatory domains that 
are involved in IAP function. 
Our analysis identifies c-IAPl and c-IAP2 as candidate 
signal transducers based on their association with a 78 
amino acid region in TNFR2 cytoplasmic domain required 
for signaling (Rothe et al., 1994). Both IAPs are recruited 
to TNFR2 by binding to a TRAF2-TRAFl heterocomplex. 
This indirect mode of interaction suggests that c-IAPl and 
c-IAP2 may be signaling molecules not only for TNFR2 
but also for other members of the TNFR superfamily that 
bind the TRAF2-TRAFl heterocomplex (Rothe et al., 
1995). Also, these findings bear implications with respect 
to the function of TRAFl. Whereas TRAF2 and TRAF3 
have each been linked to downstream signaling events, 
i.e., NF-KB activation (Rothe et al., 1995) and induction 
of CD23 expression (Cheng et al., 1995) respectively, a 
direct contribution of TRAFl to receptor signaling has not 
yet been uncovered. Our observations now support at 
least a structural role for TRAFl in the TNFR2 signaling 
complex by functioning as an adaptor protein that enables 
the recruitment of additional signaling proteins. Conceptu- 
ally, TNFRP signaling appears to proceed via a multisub- 
unit signaling complex, in which discrete intracellular sig- 
nals may emanate from its individual components. 
Because expression of Tf?Af 7 transcripts is tissue specific 
(Rothe et al., 1994; Mosialos et al., 1995), this model im- 
plies a mechanism for generating locally restricted re- 
sponses upon ligand stimulation. In addition, TRAFl may 
also directly initiate signaling cascades distinct from 
TRAF2 and TRAFS. 
Similar to its role in the development and maintenance 
of multicellularorganisms, apoptosis has been recognized 
as an efficient host antiviral defense mechanism through 
which virally infected cells are destroyed (reviewed by 
Vaux et al., 1994; Oltvai and Korsmeyer, 1994). To ensure 
viral propagation, many DNA-containing viruses have 
evolved molecular strategies to circumvent and antago- 
nize host death signals (reviewed by Oltvai and Kors- 
meyer, 1994; Vaux et al., 1994). Among these anti-death 
mechanisms are virally acquired mimics of cellular pro- 
teins, such as BCLP, that regulate apoptosis during spe- 
cific stages of host development (reviewed by Vaux et al., 
1994; Oltvai and Korsmeyer, 1994). However, several viral 
proteins have been identified that interfere with apoptosis, 
but for which putative cellular counterparts have remained 
elusive. Among these are the ~35 and IAP families from 
baculoviruses (reviewed by Clem and Miller, 1994). Al- 
though initially isolated by genetic analysis in Spodoptera 
frugiperdacells, the ~35 protein was subsequentlydemon- 
strated to suppress apoptosis in Caenorhabditis elegans, 
Drosophila melanogaster, and mammalian cells (Sugi- 
moto et al., 1994; Hay et al., 1994; Martinou et al., 1995; 
Beidler et al., 1995). In contrast, functional analysis of ba- 
culoviral IAPs has been limited to insect cells. 
Our discovery of two closely related mammalian mem- 
bers of the IAP family raises the possibility that c-IAPl and 
c-IAP2 function to regulate cellular apoptosis. In support of 
this notion, v-IAPs have recently been shown to antago- 
nize apoptosis in Drosophila (Hay et al., 1995 [this issue 
of Cell]). However, overexpression of c-IAPl and c-IAP2 
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in mammalian cells failed to suppress cell death induced 
by TNF or Fas antigen stimulation, overproduction of the 
TNFRl-associated signaling protein TRADD, or growth 
factor deprivation (M. R., T. M. A., H. Hsu, and D. V. G., 
unpublished data). Also, whereasv-IAPs have been shown 
to suppress apoptosis induced by actinomycin D in insect 
cells (Clem and Miller, 1994), overexpression of c-IAPl 
or c-IAP2 did not antagonize actinomycin D-induced cell 
death in human HL60 cells (T. M. A. and M. R., unpub- 
lished data). The finding that c-IAPI and c-IAP2 are most 
abundantly expressed in lymphoid tissues suggests that 
they may be involved in protecting against apoptosis initi- 
ated by other events in the immune system. In this respect, 
it appears possible that TNFR2-associated IAPs might par- 
ticipate in TNF-induced proliferation of thymocytes, since 
thisTNF response is specifically mediated byTNFR2 (Tar- 
taglia et al., 1991, 1993a). 
Alternatively, c-IAPl and c-IAP2 may not contribute to 
the regulation of apoptosis. Unlike the closely related 
OplAP and CplAP, the AclAP does not sustain survival of 
infected insect cells (Birnbaum et al., 1994). This apparent 
lack of apoptosis-antagonizing acitivity of AclAP may indi- 
cate functional diversity among viral and, by analogy, per- 
haps mammalian IAPs. In this respect, a potential in- 
volvment of c-IAPs in TRAFBmediated NF-KB activation 
by TNFR2 and CD40 was not substantiated (M. R. and 
D. V. G., unpublished data). Thus, although our interaction 
analysis implicates an important role for c-IAPl and c-IAP2 
in signaling by members of the TNFR superfamily, their 
specific function in this process remains to be elucidated. 
Similarly, the functional properties of viral AclAP await 
further studies. However, all IAP family members display 
highly conserved structural features, including BIR motifs 
and RING finger domains. This common architecture pre- 
dicts equally conserved biochemical properties intrinsic 
to IAPs. To this end, our analysis represents a conceptual 
paradigm for the mechanism of action of members of the 
IAP family. 
Experimental Procedures 
Cell Culture and Biological Reagents 
The murine interleukin-2-dependent cytotoxic T cell line CT6 and hu- 
man embryonic kidney 293 cells were maintained as described pre- 
viously (Tartaglia et al., 1991; Pennica et al., 1992). The rabbit anti- 
hTNFFi2 antibodies have been described previously (Pennica et al., 
1992). The monoclonal antibody QEIO against the Myc epitope was 
provided by Ft. Schreiber. The anti-FLAG epitope monoclonal antibody 
M2 and the anti-HA epitope monoclonal an!ibody 12CA5 were pur- 
chased from Eastman Kodak Company and BAbCO, respectively. 
Purification and Amino Acid Sequencing of the 68 kDa 
TNFR2-Associated Protein 
Large-scale purification of the 66 kDa TNFR2-associated protein was 
performed according to previously described procedures (Rothe et al., 
1994). In brief, total cell extract prepared from 120 liters of CT6 cells 
(6 x 1O’O cells) was passed through a preabsorption column of 25 
ml glutathione-agarose GST-hTNF-R2icd(-37) fusion protein. The 
flowthrough was applied to a 0.25 ml Affigel 10115 GST-hTNF-RPicd 
fusion protein affinity column. As a control, the lysate was passed 
through a similar Affigel lo/15 GST-hTNF-R2icd(-37) fusion protein 
affinity column in parallel. After extensive washing, bound proteins 
were eluted with ImmunoPure Gentle AglAb Elution Suffer (Pierce) 
containing 0.1 M DTT, precipitated with methanol/chloroform, and re- 
suspended in SDS sample buffer containing 5% SDS. An aliquot of 
the material was separated by 6% SDS-PAGE under reducing condi- 
tions and visualized by silver staining. The remaining purified material 
was separated by SDS-PAGE and electrophoretically transfered to 
PVDF sequencing membrane (Millipore), and proteins were visualized 
by staining with Coomassie brilliant blue R-250 (Sigma). The proteins 
bands of 66 kDa and 66 kDa were cut out and subjected to amino 
acid sequencing as described previously (Rothe et al., 1994). 
cDNA Cloning and Northern Blot Hybridization 
Reverse transcription of poly(A)+ RNA isolated from CT6 cells (Sam- 
brooket al., 1989) was performed using thecDNACycle Kit(Invitrogen) 
according to the instructions of the manufacturer. First-strand CT6 
cDNA was subjected to PCR with combinations of fully degenerate 
oligonucleotides corresponding to the sense and antisense sequences 
of obtained peptides using a Cetus GeneAmp Kit and Perkin-Elmer 
Thermocycler, The PCR was run for 35 cycles (45 s at 95X; 60 s at 
55OC; 150 sat 72’C) after an initial step of 6 min at 95OC and analyzed 
by electrophoresis on a 1.2% agarose gel. A specifically amplified 
0.75 kb DNA fragment was labeled with [&*P]dCTP using the T7 
Quick Prime Kit (Pharmacia). The labeled fragment was used to screen 
murine CT6 and human HeLa cDNA libraries (Rothe et al., 1994; Hsu 
et al., 1995) under standard high and reduced stringency conditions, 
respectively (Sambrook et al., 1989). The cDNA inserts of positive 
phage clones were subcloned into pBluescript KS (Stratagene) and 
sequenced on both strands with Sequenase (United States Sio- 
chemical). 
Northern blot analysis of mouse and human multiple tissue blots 
(Clontech) was done under high stringency conditions according to the 
instructions of the manufacturer with radiolabeled c-/API and c-IAP2 
cDNA probes. 
Yeast Two-Hybrid Assay 
DNA fragments encoding full-length and truncated variants of human 
c-IAPl and c-IAP2 were amplified from the corresponding cDNAs by 
PCR and cloned in-frame into the GAL4 DNA-binding domain vector 
pPC97 (Chevray and Nathans, 1992). Expression vectors for TRAFs 
and the cytoplasmic domain of TNFR2 in the yeast two-hybrid system 
have been reported (Rothe et al., 1994; Hu et al., 1994). Interaction 
analysis between bait- and prey-encoded fusion proteins in Saccharo- 
myces cerevisiae Y190 cells was done as described by the manufac- 
turer (Matchmaker Two-Hybrid System Protocol; Clontech). 
Transfections, Coimmunoprecipitations, and lmmunoblotting 
For expression in mammalian cells, the cDNAs for murine and human 
c-IAP7 and human c-IAP2 were cloned into pRK5 under the transcrip- 
tional control of the cytomegalovirus immediate-early promotor- 
enhancer (Schall et al., 1990). Expression vectors for TNFRZ and 
TRAFs have been described previously (Tartaglia et al., 1993b; Hu et 
al., 1994; Rothe et al., 1995). Epitope tag constructs were made by 
N-terminal addition of DNA encoding the sequences MASMEQKLI- 
SEEDL (Myc epitope tag) or MDYKDDDDK (FLAG epitope tag). 
For coprecipitation experiments with GST fusion proteins, 5 x lo6 
293 cells per dish were seeded into 150 mm dishes and transfected 
the next day by the calcium phosphate precipitation method (Ausubel 
et al., 1967). After incubation for 36 hr, cells were washed twice with 
phosphate-buffered saline and then lysed in 1 ml of 0.1% NP-40 lysis 
buffer containing 50 mM HEPES (pH 7.2) 250 mM NaCI, 10% glycerol, 
2 mM EDTA, 1 mM PMSF, 1 Qglml benzamidine, 1 uglml aprotinin, 
1 pglml leupeptin. Cell lysates were incubated for 2 hr at 4OC with 
5 ul of glutathione-agarose GST-hTNF-RPicd fusion protein beads 
(Rothe et al., 1994). The beads were washed extensively with lysis 
buffer and bound proteins fractionated by 8% SDS-PAGE and trans- 
ferred to a nitrocellulose membrane. lmmunoblot analysis was per- 
formed with an anti-Myc epitope monoclonal antibody. The antibody 
was visualized with horseradish peroxidase-coupled rabbit anti- 
mouse immunoglobulin (Amersham) using the Enhanced Chemilumi- 
nescence (ECL) Western Slotting Detection System (Amersham) ac- 
cording to the instructions of the manufacturer. 
For immunoprecipitation experiments aliquots of cell lysates (one 
fifth) from transfected 293 cells (2 x 10b cells per 100 mm dish) were 
incubated with 1 nl of anti-hTNFR2 antibody or anti-FLAG epitope 
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monoclonal antibody. After 3 hr at 4%, 20 trl of protein A- or protein 
G-agarose beads (Oncogene Science) was added to the mixture and 
incubated for another hour. The precipitates were washed and ana- 
lyzed by SDS-PAGE and immunoblotting (see above). In all cases, 
expression of transfected constructs was verified by immunoblotting 
of aliquots of cell lysates. 
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